Bosh sahifaOCEA • NASDAQ
add
Ocean Biomedical Inc
0,34 $
Seans yopilganidan keyin:(13,62%)+0,047
0,39 $
Yopilgan:27-yan, 17:05:31 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
0,42 $
Kunlik diapazon
0,34 $ - 0,45 $
Yillik diapazon
0,34 $ - 7,79 $
Bozor kapitalizatsiyasi
11,96 mln USD
Oʻrtacha hajm
449,94 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 768,00 ming | -71,07% |
Sof foyda | -5,53 mln | 60,76% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | — | — |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | — | — |
Jami aktivlari | 1,13 mln | 9,80% |
Jami passivlari | 99,22 mln | 30,11% |
Umumiy kapital | -98,08 mln | — |
Tarqatilgan aksiyalar | 34,87 mln | — |
Narxi/balansdagi bahosi | -0,15 | — |
Aktivlardan daromad | -128,73% | — |
Kapitaldan daromad | 2,46% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -5,53 mln | 60,76% |
Operatsiyalardan naqd pul | -885,00 ming | 21,68% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 896,00 ming | — |
Naqd pulning sof oʻzgarishi | 11,00 ming | 100,97% |
Boʻsh pul | 1,62 mln | 294,11% |
Haqida
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Tashkil etilgan
2019
Xodimlar soni
7
